Coherent VersaPulse Select Is First Holmium Laser For BPH Cleared By FDA
This article was originally published in The Gray Sheet
Executive SummaryCoherent's VersaPulse Select holmium laser system, cleared by FDA via 510(k) May 20 for treatment of benign prostatic hyperplasia and available immediately, is the first holmium laser cleared for use in BPH procedures.
You may also be interested in...
All medtech in Brazil will soon be subject to standardized industrial tariffs and development-related fiscal incentives, following a reform of rules relating to ICT across all industries.
The first vaccine for the new coronavirus has entered the clinic, with US firm Moderna leading the race.
Korean vaccine specialist SK Bioscience moves to develop versatile platform technology to deal with outbreaks of infectious diseases such as the new coronavirus, as the number of infections in the country surges.